Figure 4
Figure 4. CD16− monocytes control TNF-α–mediated Helios− Treg proliferation. Purified T cells were co-cultured with purified autologous CD14+CD16− cells without or with CD16+ monocytes in the presence of neutralizing (A) anti–TNF-α or (B) anti-TNFRII, and after 7 days of stimulation with anti-CD3, the frequencies of Foxp3hi (“Total Tregs”) as well as Foxp3hiHelios+ (“Helios+ Tregs”) and Foxp3hiHelios− (“Helios− Tregs”) in the CFSElo CD4+ subset were analyzed. The P value was calculated by paired t-test comparing the effects of treatment with neutralization antibody relative to IgG control. In co-cultures without CD16+ cells, anti–TNF-α treatment decreased Helios+ proliferation but increased Helios− Treg expansion, similar to data obtained when total monocytes were used. In the presence of CD16+ monocytes, Helios− Tregs were expanded relative to IgG control. (B) The same assays were performed as in (A) except that for TNF-α blockade, anti-TNFRII was used instead of anti–TNF-α. In co-cultures without CD16+ cells, anti-TNFRII treatment only affected Helios− Treg proliferation as indicated by P values, similar to data obtained when total monocytes (Figure 3A) were used.

CD16 monocytes control TNF-α–mediated Helios Treg proliferation. Purified T cells were co-cultured with purified autologous CD14+CD16 cells without or with CD16+ monocytes in the presence of neutralizing (A) anti–TNF-α or (B) anti-TNFRII, and after 7 days of stimulation with anti-CD3, the frequencies of Foxp3hi (“Total Tregs”) as well as Foxp3hiHelios+ (“Helios+ Tregs”) and Foxp3hiHelios (“Helios Tregs”) in the CFSElo CD4+ subset were analyzed. The P value was calculated by paired t-test comparing the effects of treatment with neutralization antibody relative to IgG control. In co-cultures without CD16+ cells, anti–TNF-α treatment decreased Helios+ proliferation but increased Helios Treg expansion, similar to data obtained when total monocytes were used. In the presence of CD16+ monocytes, Helios Tregs were expanded relative to IgG control. (B) The same assays were performed as in (A) except that for TNF-α blockade, anti-TNFRII was used instead of anti–TNF-α. In co-cultures without CD16+ cells, anti-TNFRII treatment only affected Helios Treg proliferation as indicated by P values, similar to data obtained when total monocytes (Figure 3A) were used.

Close Modal

or Create an Account

Close Modal
Close Modal